View in EDS

Gemcitabine plus erlotinib followed by capecitabine versus capecitabine plus erlotinib followed by gemcitabine in advanced pancreatic cancer: final results of a randomised phase 3 trial of the 'Arbeitsgemeinschaft Internistische Onkologie' (AIO-PK0104).

Saved in:
Bibliographic Details
Title: Gemcitabine plus erlotinib followed by capecitabine versus capecitabine plus erlotinib followed by gemcitabine in advanced pancreatic cancer: final results of a randomised phase 3 trial of the 'Arbeitsgemeinschaft Internistische Onkologie' (AIO-PK0104).
Authors: Heinemann, Volker1 volker.heinemann@med.uni-muenchen.de, Vehling-Kaiser, Ursula2, Waldschmidt, Dirk3, Kettner, Erika4, Märten, Angela5, Winkelmann, Cornelia6, Klein, Stefan7, Kojouharoff, Georgi8, Gauler, Thomas C.9, Fischer von Weikersthal, Ludwig10, Clemens, Michael R.11, Geissler, Michael12, Greten, Tim F.13, Hegewisch-Becker, Susanna14, Rubanov, Oleg15, Baake, Gerold16, Höhler, Thomas17, Ko, Yon D.18, Jung, Andreas19, Neugebauer, Sascha20
Source: Gut (0017-5749). May2013, Vol. 62 Issue 5, p751-759. 9p. 1 Diagram, 6 Charts, 2 Graphs.
Database: Academic Search Ultimate
Description
ISSN:00175749
DOI:10.1136/gutjnl-2012-302759